509 related articles for article (PubMed ID: 17652384)
1. Molecular determinants of antiviral potency of paramyxovirus entry inhibitors.
Porotto M; Carta P; Deng Y; Kellogg GE; Whitt M; Lu M; Mungall BA; Moscona A
J Virol; 2007 Oct; 81(19):10567-74. PubMed ID: 17652384
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of hendra virus fusion.
Porotto M; Doctor L; Carta P; Fornabaio M; Greengard O; Kellogg GE; Moscona A
J Virol; 2006 Oct; 80(19):9837-49. PubMed ID: 16973588
[TBL] [Abstract][Full Text] [Related]
3. Viral entry inhibitors targeted to the membrane site of action.
Porotto M; Yokoyama CC; Palermo LM; Mungall B; Aljofan M; Cortese R; Pessi A; Moscona A
J Virol; 2010 Jul; 84(13):6760-8. PubMed ID: 20357085
[TBL] [Abstract][Full Text] [Related]
4. Nipah and Hendra Virus Glycoproteins Induce Comparable Homologous but Distinct Heterologous Fusion Phenotypes.
Bradel-Tretheway BG; Zamora JLR; Stone JA; Liu Q; Li J; Aguilar HC
J Virol; 2019 Jul; 93(13):. PubMed ID: 30971473
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Henipavirus fusion and infection by heptad-derived peptides of the Nipah virus fusion glycoprotein.
Bossart KN; Mungall BA; Crameri G; Wang LF; Eaton BT; Broder CC
Virol J; 2005 Jul; 2():57. PubMed ID: 16026621
[TBL] [Abstract][Full Text] [Related]
6. Novel Functions of Hendra Virus G N-Glycans and Comparisons to Nipah Virus.
Bradel-Tretheway BG; Liu Q; Stone JA; McInally S; Aguilar HC
J Virol; 2015 Jul; 89(14):7235-47. PubMed ID: 25948743
[TBL] [Abstract][Full Text] [Related]
7. Single amino acid changes in the Nipah and Hendra virus attachment glycoproteins distinguish ephrinB2 from ephrinB3 usage.
Negrete OA; Chu D; Aguilar HC; Lee B
J Virol; 2007 Oct; 81(19):10804-14. PubMed ID: 17652392
[TBL] [Abstract][Full Text] [Related]
8. Third Helical Domain of the Nipah Virus Fusion Glycoprotein Modulates both Early and Late Steps in the Membrane Fusion Cascade.
Zamora JLR; Ortega V; Johnston GP; Li J; André NM; Monreal IA; Contreras EM; Whittaker GR; Aguilar HC
J Virol; 2020 Sep; 94(19):. PubMed ID: 32669342
[TBL] [Abstract][Full Text] [Related]
9. Prefusion stabilization of the Hendra and Langya virus F proteins.
Byrne PO; Blade EG; Fisher BE; Ambrozak DR; Ramamohan AR; Graham BS; Loomis RJ; McLellan JS
J Virol; 2024 Feb; 98(2):e0137223. PubMed ID: 38214525
[TBL] [Abstract][Full Text] [Related]
10. Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infection.
Yun T; Park A; Hill TE; Pernet O; Beaty SM; Juelich TL; Smith JK; Zhang L; Wang YE; Vigant F; Gao J; Wu P; Lee B; Freiberg AN
J Virol; 2015 Jan; 89(2):1242-53. PubMed ID: 25392218
[TBL] [Abstract][Full Text] [Related]
11. Receptor binding, fusion inhibition, and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of Hendra virus.
Bossart KN; Crameri G; Dimitrov AS; Mungall BA; Feng YR; Patch JR; Choudhary A; Wang LF; Eaton BT; Broder CC
J Virol; 2005 Jun; 79(11):6690-702. PubMed ID: 15890907
[TBL] [Abstract][Full Text] [Related]
12. Headless Henipaviral Receptor Binding Glycoproteins Reveal Fusion Modulation by the Head/Stalk Interface and Post-receptor Binding Contributions of the Head Domain.
Yeo YY; Buchholz DW; Gamble A; Jager M; Aguilar HC
J Virol; 2021 Sep; 95(20):e0066621. PubMed ID: 34288734
[TBL] [Abstract][Full Text] [Related]
13. Multiple Strategies Reveal a Bidentate Interaction between the Nipah Virus Attachment and Fusion Glycoproteins.
Stone JA; Vemulapati BM; Bradel-Tretheway B; Aguilar HC
J Virol; 2016 Dec; 90(23):10762-10773. PubMed ID: 27654290
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Nipah virus infection in vivo: targeting an early stage of paramyxovirus fusion activation during viral entry.
Porotto M; Rockx B; Yokoyama CC; Talekar A; Devito I; Palermo LM; Liu J; Cortese R; Lu M; Feldmann H; Pessi A; Moscona A
PLoS Pathog; 2010 Oct; 6(10):e1001168. PubMed ID: 21060819
[TBL] [Abstract][Full Text] [Related]
15. Inhibiting Human Parainfluenza Virus Infection by Preactivating the Cell Entry Mechanism.
Bottom-Tanzer SF; Rybkina K; Bell JN; Alabi CA; Mathieu C; Lu M; Biswas S; Vasquez M; Porotto M; Melero JA; Más V; Moscona A
mBio; 2019 Feb; 10(1):. PubMed ID: 30782664
[TBL] [Abstract][Full Text] [Related]
16. Basis for fusion inhibition by peptides: analysis of the heptad repeat regions of the fusion proteins from Nipah and Hendra viruses, newly emergent zoonotic paramyxoviruses.
Xu Y; Gao S; Cole DK; Zhu J; Su N; Wang H; Gao GF; Rao Z
Biochem Biophys Res Commun; 2004 Mar; 315(3):664-70. PubMed ID: 14975752
[TBL] [Abstract][Full Text] [Related]
17. Henipavirus mediated membrane fusion, virus entry and targeted therapeutics.
Steffen DL; Xu K; Nikolov DB; Broder CC
Viruses; 2012 Feb; 4(2):280-308. PubMed ID: 22470837
[TBL] [Abstract][Full Text] [Related]
18. Nipah virus attachment glycoprotein stalk C-terminal region links receptor binding to fusion triggering.
Liu Q; Bradel-Tretheway B; Monreal AI; Saludes JP; Lu X; Nicola AV; Aguilar HC
J Virol; 2015 Feb; 89(3):1838-50. PubMed ID: 25428863
[TBL] [Abstract][Full Text] [Related]
19. An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections.
Dang HV; Chan YP; Park YJ; Snijder J; Da Silva SC; Vu B; Yan L; Feng YR; Rockx B; Geisbert TW; Mire CE; Broder CC; Veesler D
Nat Struct Mol Biol; 2019 Oct; 26(10):980-987. PubMed ID: 31570878
[TBL] [Abstract][Full Text] [Related]
20. A functional henipavirus envelope glycoprotein pseudotyped lentivirus assay system.
Khetawat D; Broder CC
Virol J; 2010 Nov; 7():312. PubMed ID: 21073718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
